机构:[1]Department of Ophthalmology, Medical Faculty Mannheim, Ruprecht-Karls-University, Seegartenklinik Heidelberg, Germany[2]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory研究所眼科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[3]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing, China.首都医科大学附属北京同仁医院首都医科大学附属同仁医院
The main proven risk factor for glaucomatous optic neuropathy (GON) is an intraocular pressure (IOP) higher than the pressure sensibility of the optic nerve head allows. Fulfilling Koch postulates, numerous studies have shown that the presence of high IOP leads to GON, that lowering IOP stops the progression of GON, and that a re-increase in IOP again causes the progression of GON. There are, however, many patients with glaucoma who have statistically normal or low IOP, and despite low IOP values, they develop progressing GON. These observations led to findings that IOP is only 1 of 2 determinants of the translamina cribrosa pressure difference (TLCPD), which is the main pressure-related parameter for the physiology and pathophysiology of the optic nerve head. The second parameter influencing TLCPD is orbital cerebrospinal fluid pressure (CSFP) as the counter pressure against IOP across the lamina cribrosa. Recent experimental and clinical studies have suggested that a low CSFP could be associated with GON in normal-pressure glaucoma. These investigations included studies with an experimental long-term reduction in CSFP in monkeys, population-based studies, and clinical retrospective and prospective investigations on patients with normal-pressure glaucoma. Besides TLCPD, other ocular parameters influenced by CSFP may be choroidal thickness, retinal vein pressure and diameter, occurrence of retinal vein occlusions, and occurrence and severity of diabetic retinopathy.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
无
最新[2023]版:
大类|3 区医学
小类|2 区眼科学
第一作者:
第一作者机构:[1]Department of Ophthalmology, Medical Faculty Mannheim, Ruprecht-Karls-University, Seegartenklinik Heidelberg, Germany[2]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory
通讯作者:
通讯机构:[2]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory[3]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing, China.[*1]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, No. 1 Dongjiaominxiang St, Dongcheng District, Beijing, China. 100730.
推荐引用方式(GB/T 7714):
Jonas Jost B,Wang Ningli,Yang Diya.Translamina Cribrosa Pressure Difference as Potential Element in the Pathogenesis of Glaucomatous Optic Neuropathy.[J].Asia-Pacific Journal Of Ophthalmology (Philadelphia, Pa.).2016,5(1):5-10.doi:10.1097/APO.0000000000000170.
APA:
Jonas Jost B,Wang Ningli&Yang Diya.(2016).Translamina Cribrosa Pressure Difference as Potential Element in the Pathogenesis of Glaucomatous Optic Neuropathy..Asia-Pacific Journal Of Ophthalmology (Philadelphia, Pa.),5,(1)
MLA:
Jonas Jost B,et al."Translamina Cribrosa Pressure Difference as Potential Element in the Pathogenesis of Glaucomatous Optic Neuropathy.".Asia-Pacific Journal Of Ophthalmology (Philadelphia, Pa.) 5..1(2016):5-10